Considering Robotic Surgery For Breast Cancer? Proceed With Caution, FDA Says

Though the FDA has approved robotic assisted surgery for many procedures, the US agency cautions that safety and efficacy of the technology has not been well-established for cancer-related surgeries, particularly mastectomies.

ROBOTIC ASSISTED SURGERY.
• Source: Alamy

In many cases, robotically assisted surgery (RAS) offers patients a less invasive procedure than traditional surgery, with smaller incisions and less scarring, lower infection rates, quicker recovery and reduced pain.

But the Food and Drug Administration is reminding breast cancer patients that RAS might not be the best option for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

From ‘Work Harder’ to ‘Phenomenal People’: Makary’s FDA About-Face

 

In his first 100 days as FDA commissioner, Martin Makary has gone from vocal critic to vocal supporter of the agency’s staff, calling them “phenomenal” and praising their dedication—even as morale remains shaken by recent layoffs and restructuring.

Time For Medtech To Have Its Say On Critical Changes In EU Framework Legislation

 

In revising the foundations of EU product legislation, the European Commission aims to increase harmonization, cut regulatory burdens and promote digital tools to boost compliance and safety.

HHS Suggests Drastic Reductions To Skin Substitute Payments

 
• By 

The US Department of Health and Human Services has proposed cutting Medicare reimbursement for skin substitutes used in chronic wound care by up to 90%. The change aims to address rising costs but could harm patient access and treatment quality, prompting concerns from industry stakeholders.